๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A New Orally Bioavailable Dual Adenosine A2B/A3 Receptor Antagonist with Therapeutic Potential.

โœ Scribed by Neil J. Press; et al. et al.


Publisher
John Wiley and Sons
Year
2005
Weight
16 KB
Volume
36
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Potent antagonists for the human adenosi
โœ Maarten de Zwart; Roel C. Vollinga; Margot W. Beukers; Danielle F. Sleegers; Jac ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 147 KB ๐Ÿ‘ 2 views

A series of novel and known 5-substituted 7-amino-2-(2-furyl) [1,2,4]triazolo [1,5a][1,3,5]triazine derivatives were synthesized and tested for adenosine receptor antagonism in radioligand binding assays at all four adenosine receptor subtypes and for inhibition of the agonist-induced cyclic AMP res

1,3-dialkylxanthine derivatives having h
โœ Kenneth A. Jacobson; Ad P. Ijzerman; Joel Linden ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 179 KB ๐Ÿ‘ 2 views

The structure-activity relationships (SAR) of alkylxanthine derivatives as antagonists at the recombinant human adenosine receptors were explored in order to identify selective antagonists of A 2B receptors. The effects of lengthening alkyl substituents from methyl to butyl at 1-and 3-positions and